The Simons Foundation Inc. – Trademark Portfolio
Entity Type: 03
The Simons Foundation Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FLATIRON INSTITUTE. The owner is based in New York, NY.
160 Fifth Avenue
7th Floor
New York, NY 10010
Showing of trademarks Trademarks
Trademark Classifications
The Simons Foundation Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does The Simons Foundation Inc. have?
The Simons Foundation Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does The Simons Foundation Inc. file in?
The Simons Foundation Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are The Simons Foundation Inc.'s most well-known trademarks?
The Simons Foundation Inc.'s registered trademark portfolio includes well-known marks such as FLATIRON INSTITUTE. These are among 1 currently registered trademark in the portfolio.
What is The Simons Foundation Inc.'s trademark registration success rate?
The Simons Foundation Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.